In a phase II study, 16 adult patients with locally advanced or metastatic soft tissue sarcomas were treated with i.v. infusions of ifosfamide/mesna 5 g/m2 plus i.v. doxorubicin 40 mg/m2. Courses were given every 3 weeks up to a maximum of six courses in responding patients. Six patients (37.5%) had
✦ LIBER ✦
Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults
✍ Scribed by P. Dombernowsky; H. Mouridsen; J. Schütte; A. Santoro; J. Rouessé; R. Somers; W. Stewart; H. M. Pinedo; A. v. Oosterom; G. Blackledge; D. Thomas; R. Sylvester fór
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 51 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A phase II study of ifosfamide/mesna wit
✍
Brian M. J. Cantwell; James Carmichael; Sarah Ghani; Adrian L. Harris
📂
Article
📅
1988
🏛
Springer
🌐
English
⚖ 418 KB
Ifosfamide plus mesna with and without a
✍
E. Wiltshaw; G. Westbury; C. Harmer; A. McKinna; C. Fisher
📂
Article
📅
1986
🏛
Springer
🌐
English
⚖ 263 KB
Ifosfamide, vincristine, doxorubicin and
✍
Tom A. Wiklund; Carl P. Blomqvist; Martti Virolainen; Inkeri Elomaa
📂
Article
📅
1992
🏛
Springer
🌐
English
⚖ 552 KB
Cyclophosphamide versus ifosfamide: prel
✍
Vivien H. C. Bramwell; H. T. Mouridsen; A. Santoro; G. Blackledge; R. Somers; D.
📂
Article
📅
1986
🏛
Springer
🌐
English
⚖ 442 KB
Phase II trial of echinomycin in advance
✍
Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson
📂
Article
📅
1990
🏛
Springer US
🌐
English
⚖ 232 KB
Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin
Oral piritrexim — A phase II study in pa
✍
Judith D. Schiesel; Matthew Carabasi; Gordon Magill; Ephraim Casper; Edgar Cheng
📂
Article
📅
1992
🏛
Springer US
🌐
English
⚖ 129 KB